BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24656405)

  • 1. RETRACTED: Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule.
    Kitambi SS; Toledo EM; Usoskin D; Wee S; Harisankar A; Svensson R; Sigmundsson K; Kalderén C; Niklasson M; Kundu S; Aranda S; Westermark B; Uhrbom L; Andäng M; Damberg P; Nelander S; Arenas E; Artursson P; Walfridsson J; Forsberg Nilsson K; Hammarström LGJ; Ernfors P
    Cell; 2014 Apr; 157(2):313-328. PubMed ID: 24656405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The soft underbelly of tumor cells.
    Shi Y; Lim SK; Parada LF
    Cell Res; 2014 Aug; 24(8):910-1. PubMed ID: 24874955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Oncolytic Efficacy and in Vivo Pharmacokinetics of [2-(4-Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) Are Governed by Distinct Stereochemical Features.
    Hammarström LG; Harmel RK; Granath M; Ringom R; Gravenfors Y; Färnegårdh K; Svensson PH; Wennman D; Lundin G; Roddis Y; Kitambi SS; Bernlind A; Lehmann F; Ernfors P
    J Med Chem; 2016 Sep; 59(18):8577-92. PubMed ID: 27607569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driving glioblastoma to drink.
    Gilbertson RJ
    Cell; 2014 Apr; 157(2):289-290. PubMed ID: 24725398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer: turning glioblastoma cells vacuous.
    Cully M
    Nat Rev Drug Discov; 2014 Jun; 13(6):417. PubMed ID: 24854406
    [No Abstract]   [Full Text] [Related]  

  • 6. Vacquinol-1 inducible cell death in glioblastoma multiforme is counter regulated by TRPM7 activity induced by exogenous ATP.
    Sander P; Mostafa H; Soboh A; Schneider JM; Pala A; Baron AK; Moepps B; Wirtz CR; Georgieff M; Schneider M
    Oncotarget; 2017 May; 8(21):35124-35137. PubMed ID: 28410232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model.
    Zeng A; Ye T; Cao D; Huang X; Yang Y; Chen X; Xie Y; Yao S; Zhao C
    Sci Rep; 2017 Oct; 7(1):14372. PubMed ID: 29085081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions.
    Sengupta R; Barone A; Marasa J; Taylor S; Jackson E; Warrington NM; Rao S; Kim AH; Leonard JR; Piwnica-Worms D; Rubin JB
    Oncotarget; 2015 Jul; 6(21):18282-92. PubMed ID: 26286961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy.
    Arden JD; Lavik KI; Rubinic KA; Chiaia N; Khuder SA; Howard MJ; Nestor-Kalinoski AL; Alberts AS; Eisenmann KM
    Mol Biol Cell; 2015 Nov; 26(21):3704-18. PubMed ID: 26354425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.
    Zhao HF; Wang J; Jiang HR; Chen ZP; To SS
    J Exp Clin Cancer Res; 2016 May; 35():78. PubMed ID: 27176481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
    Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
    Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.
    de Boüard S; Herlin P; Christensen JG; Lemoisson E; Gauduchon P; Raymond E; Guillamo JS
    Neuro Oncol; 2007 Oct; 9(4):412-23. PubMed ID: 17622648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of proapoptotic and autophagic proteins involved in the cell death of glioblastoma induced by synthetic glycans.
    Faried A; Arifin MZ; Ishiuchi S; Kuwano H; Yazawa S
    J Neurosurg; 2014 Jun; 120(6):1298-308. PubMed ID: 24678780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cellular and post-genomic technologies in the treatment of glioblastoma multiforme (Review).
    Bryukhovetskiy I; Bryukhovetskiy A; Khotimchenko Y; Mischenko P
    Oncol Rep; 2016 Feb; 35(2):639-48. PubMed ID: 26548844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
    Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
    PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel N-cadherin antagonist causes glioblastoma cell death in a 3D bioprinted co-culture model.
    Smits IPM; Blaschuk OW; Willerth SM
    Biochem Biophys Res Commun; 2020 Aug; 529(2):162-168. PubMed ID: 32703405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.